Telemedicine Allows for First-of-its-Kind Trial Administering Subcutaneous Immunotherapy at Home
As more agents are developed in subcutaneous forms rather than or in addition to intravenous forms, delivery methods can evolve to allow for home administration of certain agents, according to Jorge J. Nieva, MD, who added that telemedicine will allow …